NASDAQ
11.71USD
-0.58 (-4.72%)
We have scored 18 news catalysts on electroCore, Inc. (ECOR) over the past 12 months. The biggest single-day move next to one of them came Sep 2, 2026, when ECOR closed +5.1%: “Ecora Royalties PLC Announces Half Year Results”. Coverage across the window leans positive (average ticker sentiment +0.63). Most of the impact sits in revenue growth rate and revenue cyclicality.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
103.3M
P/E
—
EPS
—
Beta
1.01
52W range
4.41-12.7
Day range
11.57–12.13
Open
12.04
Prev close
12.29
Volume
63.3K
Avg volume
105.2K
Dividend
0.00
IPO
2018-06-22
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about electroCore, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for ECOR: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
